BNP Paribas Financial Markets’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.5M | Buy |
379,597
+258,557
| +214% | +$38.8M | 0.02% | 676 |
|
|
2026
Q1 | $18.5M | Buy |
121,040
+45,683
| +61% | +$7M | 0.01% | 1212 |
|
|
2025
Q4 | $10.4M | Sell |
75,357
-108,887
| -59% | -$14.3M | ﹤0.01% | 1584 |
|
|
2025
Q3 | $23.6M | Buy |
184,244
+182,663
| +11,554% | +$22.3M | 0.01% | 1023 |
|
|
2025
Q2 | $191K | Sell |
1,581
-283
| -15% | -$31.9K | ﹤0.01% | 3782 |
|
|
2025
Q1 | $208K | Sell |
1,864
-96,114
| -98% | -$10.2M | ﹤0.01% | 3670 |
|
|
2024
Q4 | $9.53M | Buy |
97,978
+72,088
| +278% | +$7.69M | 0.01% | 1385 |
|
|
2024
Q3 | $2.98M | Buy |
25,890
+1,552
| +6% | +$176K | ﹤0.01% | 1811 |
|
|
2024
Q2 | $2.59M | Buy |
24,338
+13,839
| +132% | +$1.39M | ﹤0.01% | 1767 |
|
|
2024
Q1 | $1.02M | Buy |
10,499
+2,463
| +31% | +$253K | ﹤0.01% | 2489 |
|
|
2023
Q4 | $811K | Buy |
8,036
+7,480
| +1,345% | +$722K | ﹤0.01% | 2512 |
|
|
2023
Q3 | $56.6K | Sell |
556
-868
| -61% | -$88.1K | ﹤0.01% | 3443 |
|
|
2023
Q2 | $144K | Sell |
1,424
-21
| -1% | -$2.1K | ﹤0.01% | 3132 |
|
|
2023
Q1 | $133K | Buy |
1,445
+698
| +93% | +$61K | ﹤0.01% | 3253 |
|
|
2022
Q4 | $67.8K | Buy |
747
+63
| +9% | +$5.31K | ﹤0.01% | 3354 |
|
|
2022
Q3 | $52K | Sell |
684
-278
| -29% | -$23K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $81.3K | Sell |
962
-1,470
| -60% | -$129K | ﹤0.01% | 3416 |
|
|
2022
Q1 | $213K | Sell |
2,432
-4,553
| -65% | -$394K | ﹤0.01% | 3107 |
|
|
2021
Q4 | $611K | Buy |
6,985
+1,811
| +35% | +$150K | ﹤0.01% | 2907 |
|
|
2021
Q3 | $423K | Buy |
5,174
+502
| +11% | +$45.2K | ﹤0.01% | 2808 |
|
|
2021
Q2 | $426K | Buy |
4,672
+4,211
| +913% | +$375K | ﹤0.01% | 2604 |
|
|
2021
Q1 | $39.4K | Sell |
461
-245
| -35% | -$22K | ﹤0.01% | 3660 |
|
|
2020
Q4 | $66.7K | Buy |
706
+31
| +5% | +$2.71K | ﹤0.01% | 3421 |
|
|
2020
Q3 | $58.7K | Sell |
675
-167
| -20% | -$14.5K | ﹤0.01% | 3394 |
|
|
2020
Q2 | $73.5K | Sell |
842
-200
| -19% | -$17.3K | ﹤0.01% | 2887 |
|
|
2020
Q1 | $85.9K | Sell |
1,042
-299
| -22% | -$26.7K | ﹤0.01% | 3286 |
|
|
2019
Q4 | $127K | Sell |
1,341
-358
| -21% | -$32.1K | ﹤0.01% | 3177 |
|
|
2019
Q3 | $148K | Buy |
1,699
+133
| +8% | +$11.9K | ﹤0.01% | 2908 |
|
|
2019
Q2 | $143K | Buy |
1,566
+64
| +4% | +$5.42K | ﹤0.01% | 2820 |
|
|
2019
Q1 | $129K | Hold |
1,502
| – | – | ﹤0.01% | 2968 |
|
|
2018
Q4 | $116K | Hold |
1,502
| – | – | ﹤0.01% | 2272 |
|
|
2018
Q3 | $116K | Sell |
1,502
-2,384
| -61% | -$176K | ﹤0.01% | 2664 |
|
|
2018
Q2 | $263K | Buy |
3,886
+2,902
| +295% | +$200K | ﹤0.01% | 2308 |
|
|
2018
Q1 | $71.3K | Buy |
984
+42
| +4% | +$3.2K | ﹤0.01% | 3365 |
|
|
2017
Q4 | $70.9K | Hold |
942
| – | – | ﹤0.01% | 3478 |
|
|
2017
Q3 | $72.5K | Buy |
942
+18
| +2% | +$1.36K | ﹤0.01% | 2954 |
|
|
2017
Q2 | $69.1K | Sell |
924
-42
| -4% | -$2.98K | ﹤0.01% | 3013 |
|
|
2017
Q1 | $64.3K | Buy |
966
+42
| +5% | +$2.8K | ﹤0.01% | 2654 |
|
|
2016
Q4 | $60.3K | Hold |
924
| – | – | ﹤0.01% | 2744 |
|
|
2016
Q3 | $65.4K | Hold |
924
| – | – | ﹤0.01% | 2313 |
|
|
2016
Q2 | $68.3K | Hold |
924
| – | – | ﹤0.01% | 2229 |
|
|
2016
Q1 | $60K | Sell |
924
-1,315
| -59% | -$89.5K | ﹤0.01% | 1949 |
|
|
2015
Q4 | $173K | Sell |
2,239
-160
| -7% | -$12.7K | ﹤0.01% | 2037 |
|
|
2015
Q3 | $198K | Sell |
2,399
-57
| -2% | -$5.07K | ﹤0.01% | 1960 |
|
|
2015
Q2 | $216K | Buy |
2,456
+1,340
| +120% | +$123K | ﹤0.01% | 1678 |
|
|
2015
Q1 | $98.6K | Hold |
1,116
| – | – | ﹤0.01% | 1737 |
|
|
2014
Q4 | $92.7K | Buy |
1,116
+1,115
| +111,500% | +$92.4K | ﹤0.01% | 1536 |
|
|
2014
Q3 | $94 | Sell |
1
-12
| -92% | -$971 | ﹤0.01% | 4059 |
|
|
2014
Q2 | $1.09K | Buy |
13
+1
| +8% | +$79 | ﹤0.01% | 3404 |
|
|
2014
Q1 | $956 | Hold |
12
| – | – | ﹤0.01% | 2875 |
|
|
2013
Q4 | $884 | Buy |
+12
| New | +$834 | ﹤0.01% | 3858 |
|
Other funds holding NVS
BNP Paribas Financial Markets's NVS Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Novartis (NVS) stake by 214% in Q2 2026, buying an estimated $38.8M and bringing the position to 379,597 shares worth $59.5M. The position accounts for 0.02% of the portfolio, ranked #676.
BNP Paribas Financial Markets first reported a position in NVS in Q4 2013 and has held it in 51 quarters since. 1,546 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- BNP Paribas Financial Markets held 379,597 shares of Novartis worth $59.5M as of Q2 2026.
- BNP Paribas Financial Markets bought 258,557 Novartis shares in Q2 2026, an estimated $38.8M.
- Novartis made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #676 holding.
- BNP Paribas Financial Markets first reported a position in Novartis in Q4 2013 and has held it in 51 quarters since.
- 1,546 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.